Wednesday, October 21, 2026

Meta 3Q26 Business Update: Not Just an Ads Business?

Meta’s 3Q26 Family of Apps revenue rose 26% as Muse reached 10 million users, testing AI-agent shopping that Walmart permits while Amazon blocks.

META $1.8T

Speedwell Research 45h ago 10 clicks

Oct 21 BMBL $783M

Bumble is being taken private

Modern Value Investing 8 clicks

Oct 21 NFLX $511B

Netflix Q3 Earnings Update

Rebound Capital 20 clicks

From X

@ActAccordingly 43h ago 5 clicks

PAA Research on X

One mantra rules everything right now in the AI space: BE FIRST! $SPCX pulled forward its earnings release date, $META rushes to form a new class of shares, and we'll see what the other hyperscalers have to say in the next 7-10 days. The Anthropic bankers cannot be happy with this disclosure from $META's new share class filing tonight (so many jewels in this document, it's a must read): "The Special Committee also recognized that timing is important to secure capital before competitors saturate various funding options. Recent significant capital raises at other notable companies, and others soon anticipated to take place, to fund the same AI growth—for example, Alphabet, SpaceX, Anthropic, and OpenAI—have resulted in an increasingly challenging environment for raising capital. The Special Committee considered that, while the Company presently has sufficient capital resources for its current needs, in order to finance its funding needs going forward it would be prudent for the Company to do so before even more companies have absorbed available capital in the market." https://t.co/yVUhuq7dLb

@aleabitoreddit 45h ago 3 clicks

Serenity on X

$NVDA today announces capacity agreements with substrate, packaging, testing and optical engine suppliers. - Substrate agreements with Ibiden, Samsung Electro-Mechanics and Unimicron to expand by 2.5x - $AMKR to increase advanced packaging capacity by more than 300% by the end of 2028, with a new $1.3B agreement - Multibillion dollar capacity reservation advance to support Ibiden's plant in Japan - "By 2028, production allocated to $NVDA is projected to account for a significant portion of Samsung Electro-Mechanics' total annual package substrate production capacity" - KYEC with $1.1B capacity reservation in advance - SPIL for optical engine capacity for CPO by 15x by H2 2027 and double that for 2028 Well, that's a lot of news. As Jensen Huang puts it: "Demand is extraordinary. Capacity is the constraint."

@finphysnerd 45h ago

Myles on X

@JordanBoekel I've been short $WES on and off, I need to have another look at Coles and Woolworths they look very expensive.

@DeepSailCapital 45h ago 2 clicks

Deep Sail Capital on X

Kraken Robotics $PNG.NE Theon $THEON Modine $MOD Topicus $TOI.NE

@junkbondinvest 45h ago 2 clicks

junkbondinvestor on X

Netflix 5yr CDS is at its widest level since 2023, ~2.5x the February 2025 tights Still an IG-tight level but the recent direction is one way $NFLX https://t.co/99wtectSsf

@leevalueroach 45h ago 4 clicks

Lee Roach on X

$META financing capex through an equity raise that keeps the super voting shares in tact has me still on the ground rolling and laughing like an idiot. This is shit you would see out of a microcap crapco. Not a high flying “tech” company. Getting a lot of hate for talking shit. Because apparently Meta has to do this or they will “die”. I fail to see how an addictive social media platform that’s worse than smoking cigarettes is going to die by skipping out on this massive capex AI cycle. My god.

@finphysnerd 46h ago 2 clicks

Myles on X

Shorting staples here pretty aggressively, which have gone on a big run. $XLP broadly but $KO and $WMT particularly.

@BarbarianCap 46h ago 2 clicks

Barbarian Capital on X

Buyout firm EQT acquires German diagnostics group in €10.8bn deal $QGEN https://t.co/kaTEpQCpLB

Sagimet Biosciences: The U.S. Acne Trial Is A Replication Exercise, Not A Discovery Bet

Sagimet Biosciences' denifanstat enters a fully funded U.S. acne registration trial after Phase 3 results, with SGMT trading below cash and…

SGMT $695M

Equity Eagle Oct 21 3 clicks

CoreWeave: It’s Not Dying, Not Anytime Soon

CoreWeave is compared with Amazon's early public years, when investors expected bankruptcy amid losses and dependence on outside capital.

CRWV $34B

Capitalist Letters Oct 21 42 clicks

Eli Lilly And Co. (LLY)

Eli Lilly's Mounjaro and Zepbound drove 2025 revenue to $65.2 billion as the drugmaker expands AI partnerships with Nvidia, Isomorphic…

LLY $1.2T

SixSigmaCapital: Navigating the Financial Markets Oct 21 25 clicks

Gladstone Investment: High Dividend Increases And NAV Gains, But Very Risky

Gladstone Investment's 50% equity portfolio drove NAV and dividend gains, but five holdings make up 44.5% of fair value and heighten Level…

GAIN $588M

Stephen Nemo Oct 21 4 clicks

Why I sold OB pick for 26 SVM

Silvercorp’s falling Ying grades, prolonged GC suspension, El Domo execution risk and Chaarat funding needs weaken its valuation despite…

SVM $2B

The Oak Bloke Oct 21 27 clicks

ServiceNow: The Shift From Seats To 'Assists' Uncaps Exponential Growth

ServiceNow is shifting from seat-based subscriptions to usage-based AI “Assists,” expanding revenue potential across its enterprise…

NOW $152B

Raul Shah Oct 21 11 clicks

Use of AI is boosting Snowflake’s revenue while mortal companies may take longer

Snowflake says internal AI use is lifting revenue and profit, while customers show early implementation success.

SNOW $111B

The Technology Letter Oct 20 11 clicks

Netflix Earnings, Business or Franchise, Disney’s Deal

Netflix’s earnings raise questions about whether its growth profile still merits a franchise valuation, alongside discussion of Disney’s…

NFLX $511BDIS $193B

Stratechery by Ben Thompson – On the business, strategy, and impact of technology. Oct 20 8 clicks

Vicor Update, Part Three

Vicor’s $66.6 million in AI power-delivery royalties generated about $50 million of operating profit, eclipsing its module business as…

VICR $9.7B

CV's Substack Oct 20 28 clicks

From Fat to Follicles - Is Hair Loss the Next Blockbuster?

Novo Nordisk has only floated hair loss, while Veradermics’ Phase 3 oral minoxidil data lead a field of licensing and takeover candidates.

NVO $176BMANE $5.3B

Cestrian Capital Research Oct 20 41 clicks

GXO · long

GXO Logistics, Inc.

GXO Logistics is undergoing transformation under new leadership in the growing contract-logistics business.

GXO $5.6B

Value Investors Club Apr 30 4 clicks

Paxman (PAX.ST)

Paxman sells chemotherapy scalp-cooling systems, expanding US reimbursement and utilization after acquiring its largest competitor in 2025.

PXMBF $1.6B

Healthy Stock Picks Jul 28

Earnings: TSMC, NXPI, AEHR, GOOG, TXN, VAT, VICR

AEHR earnings are the focus, with a late call acknowledged alongside results from TSMC, NXP, Alphabet, Texas Instruments, VAT Group and…

AEHR $2.1B

Fabricated Knowledge Jul 25

GCI Liberty: Cheap, Tax Asset, Malone Fatigue?

GCI Liberty trades cheaply, holds tax assets, and faces investor fatigue with John Malone.

GLIBA $780M

Clark Street Value Jul 16 2 clicks

AAON

AAON shares have fallen 45% from November 2024 highs as core HVAC bookings weaken, while BASX supplies hyperscale data-center growth.

AAON $6.1B

Kairos Research Jul 16

Costco: The Perpetual Growth Machine

Costco’s 14% maximum markup and membership model recycle scale savings into consumer surplus, supporting loyalty, low competitive appeal…

COST $441B

Invested Capital Jul 12

Quiet Compounders, a Hidden Moat and an 18% FCF Yield at Pitney Bowes (PBI)

Pitney Bowes trades at an 18% FCF yield, with 25% operating margins, 30%-plus ROIC and plans to return free cash flow mostly through…

PBI $2.3B

Base Hit Investing Jul 11

BSR REIT (TSX:HOM.U)

BSR REIT’s $618.5 million sale to AvalonBay valued Texas apartments near a 5% cap rate and removed consent rights that had constrained…

RETDF $4.3B

Real Assets, Real Value Jul 8

4 High-Quality Global Compounders Hiding in Plain Sight

ASML, LVMH, Mercado Libre and CSL are presented as global compounders with durable barriers, strong brands or integrated platforms, and…

ASML $616BMELI $93B

Invested Capital Jul 5

Performance review: H1 2025

Abrdn European Logistics Income, Dream Residential and FrontView REIT returned 19%, 15% and 4% through June, with asset sales and strategic…

FVR $426M

Real Assets, Real Value Jul 2

Wednesday, October 21, 2026

PAA Research on X

Serenity on X

Myles on X

Deep Sail Capital on X

junkbondinvestor on X

Lee Roach on X

Myles on X

Barbarian Capital on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 55 of 247

X accounts we follow

Investor letters we follow

Sectors